Artículos relacionados
Área salud
Experience with erenumab: Data from real clinical practice
diciembre 27, 2022
Área salud, Elsevier España, Medicina, Neurology Perspectives, Vol. 2. Issue. 3. (July - September 2022)
Introduction The development of monoclonal antibodies against calcitonin gene-related peptide has represented a revolution in the treatment of migraine. Erenumab was the first of these drugs to be available in clinical practice in our setting. […]
Área salud
[Translated article] Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis
septiembre 26, 2023
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 6. (Junio 2023)
The advent of biosimilar drugs and their use in routine clinical practice has revolutionized the management of moderate to severe psoriasis and led to changes in the positioning of the existing molecules used to control […]
